Prolongation of morphine analgesia by competitive NMDA receptor antagonist d-CPPene (SDZ EAA 494) in rats
- 1 June 1998
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 351 (3) , 299-305
- https://doi.org/10.1016/s0014-2999(98)00324-0
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Enhancement of morphine actions in morphine-naive and morphine-tolerant mice by LY 235959, a competitive antagonist of the NMDA receptorGeneral Pharmacology: The Vascular System, 1997
- The Effects of NMDA Receptor Antagonists and Nitric Oxide Synthase Inhibitors on Opioid Tolerance and Withdrawal Medication Development Issues for Opiate AddictionNeuropsychopharmacology, 1995
- 1-aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid toleranceLife Sciences, 1994
- Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine: a preliminary reportPain, 1994
- The NMDA Receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioidsPain, 1994
- Blockade of mu and kappa1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonistLife Sciences, 1993
- NMDA receptor antagonist MK-801 blocks non-opioid stress-induced analgesia in the formalin testPain, 1992
- Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801Science, 1991
- Acute Tolerance in Morphine AnalgesiaAnesthesiology, 1991
- Effects of ethylenediamine on morphine analgesia and tolerance-dependence in miceGeneral Pharmacology: The Vascular System, 1985